MedTrace Logo

Sexual Maturation in β-Thalassemia Major Patients in Assiut University Hospital

NCT03847558 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-02-20

No results posted yet for this study

Summary

cross sectional study to asses sexual maturation in β-Thalassemia Major patients receiving Iron Chelation Therapy in assuit University Hospital and maintenance of 2ry sexual characters and reproduction

Conditions

  • β-Thalassemia Major Patients Receiving Chelation Therapy

Interventions

DIAGNOSTIC_TEST

FSH((Follicle Stimulating Hormone) and LH (Luteinizing Hormone) hormone for females and Testosterone hormone for males

assess of sexual maturation by clinical examination and hormonal studies (FSH.LH,Testosterone)

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
10 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-15
Primary Completion
2020-04-15
Completion
2020-04-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03847558 on ClinicalTrials.gov